Skip to content
Pill with imprint IX 15mg 675 15mg, brown, capsule, 16 mm (Dextroamphetamine Sulfate 15 mg)

IX 15mg 675 15mg pill

Pill with imprint IX 15mg 675 15mg is brown, capsule, 16 mm and has been identified as Dextroamphetamine Sulfate 15 mg. It is used for ADHD and narcolepsy. It is supplied by Amneal Pharmaceuticals of New York LLC.

Controlled substance: Schedule II

Dextroamphetamine Sulfate 15 mg

Imprint
IX 15mg 675 15mg
Strength
15 mg
Used for
ADHD and narcolepsy
Color
Brown
Shape
Capsule / oblong
Size
16 mm
Score
No score line
Form
Capsule, extended release
Manufacturer
Amneal Pharmaceuticals of New York LLC
Drug class
Stimulant (ADHD medicine)
NDC
0115-9929, 0115-9929-10, 64896-675, 64896-675-10

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked . Photo: Amneal Pharmaceuticals.

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Dextroamphetamine Sulfate pills and guides

What is Dextroamphetamine Sulfate used for?

Dextroamphetamine Sulfate is used for ADHD and narcolepsy.

Medicine type
Stimulant (ADHD medicine)
Official uses from the US prescribing label

Dextroamphetamine sulfate extended-release capsules are indicated in:

Narcolepsy

Attention Deficit Disorder with Hyperactivity

As an integral part of a total treatment program that typically includes other measures (psychological, educational, social) for patients (ages 6 years to 16 years) with this syndrome. A diagnosis of Attention Deficit Hyperactivity Disorder (ADHD; DSM-IV) implies the presence of the hyperactive-impulsive or inattentive symptoms that caused impairment and were present before age 7 years. The symptoms must cause clinically significant impairment, e.g., in social, academic, or occupational functioning, and be present in 2 or more settings, e.g., school (or work) and at home. The symptoms must not be better accounted for by another mental disorder. For the Inattentive Type, at least 6 of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes; lack of sustained attention; poor listener; failure to follow through on tasks; poor organization; avoids tasks requiring sustained mental effort; loses things; easily distracted; forgetful. For the Hyperactive-Impulsive Type, at least 6 of the following symptoms must have persisted for at least 6 months: fidgeting/squirming; leaving seat; inappropriate running/climbing; difficulty with quiet activities; “on the go”; excessive talking; blurting answers; can’t wait turn; intrusive. The Combined Type requires both inattentive and hyperactive-impulsive criteria to be met.

Special Diagnostic Considerations

Specific etiology of this syndrome is unknown, and there is no single diagnostic test. Adequate diagnosis requires the use of medical and special psychological, educational, and social resources. Learning may or may not be impaired. The diagnosis must be based upon a complete history and evaluation of the patient and not solely on the presences of the required number of DSM-IV characteristics.

Need for Comprehensive Treatment Program

Dextroamphetamine sulfate extended-release is indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, social) for patients with this syndrome. Drug treatment may not be indicated for all patients with this syndrome. Stimulants are not intended for use in patients who exhibit symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. Appropriate educational placement is essential and psychosocial intervention is often helpful. When remedial measures alone are insufficient, the decision to prescribe stimulant medication will depend upon the physician’s assessment of the chronicity and severity of the patient’s symptoms.

Limitations of Use The use of dextroamphetamine sulfate extended-release capsules is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage.

From the FDA-approved label on DailyMed (published Oct 02, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows IX 15mg 675 15mg. The parts can be split between the two sides, so turn the pill over and check both.
  • It is brown, capsule, 16 mm.
  • The score line, coating and any logo match the photo.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Dextroamphetamine Sulfate

Inactive: Cetyl Alcohol, D&c Yellow No. 10, Dibutyl Sebacate, Ethylcellulose (100 Mpa.s), Fd&c Red No. 40, Fd&c Yellow No. 6, Gelatin, Hypromelloses, Polyethylene Glycol, Unspecified, Povidone, Sodium Lauryl Sulfate, Fd&c Blue No. 1

Also distributed by

Amneal Pharmaceuticals LLC

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Dextroamphetamine Sulfate pills